{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T06:37:42Z","timestamp":1769755062203,"version":"3.49.0"},"reference-count":50,"publisher":"American Society of Hematology","issue":"7","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,4,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Noncanonical exon usage plays many important roles in cellular phenotypes, but its contribution to human B-cell development remains sketchily understood. To fill this gap, we collected various B-cell fractions from bone marrow (BM) and tonsil donors, performed RNA sequencing, and examined transcript variants. We identified 150 genes that harbor local splicing variations in all pairwise comparisons. One of them encodes FBXW7, an E3 ubiquitin ligase implicated as a driver in several blood cancers. Surprisingly, we discovered that in normal human pro-B cells, the predominant transcript used an alternative first exon to produce the poorly characterized FBXW7\u03b2 isoform, previously thought to be restricted to neural tissues. The FBXW7\u03b2 transcript was also abundant in cell lines and primary samples of pediatric B-cell acute lymphoblastic leukemia (B-ALL), which originates in the BM. When overexpressed in a heterologous cell system, this transcript yielded the expected protein product, as judged by anti-FLAG immunoblotting and mass spectrometry. Furthermore, in REH B-ALL cells, FBXW7\u03b2 mRNA was the only FBXW7 isoform enriched in the polyribosome fraction. To shed light on possible functions of\u00a0FBXW7\u03b2, we used gain- and loss-of-function approaches and identified an FBXW7-dependent inflammatory gene signature, apparent in a subset of B-ALL with high FBXW7\u03b2 expression. This signature contained several members of the tumor necrosis factor superfamily, including those comprising the HLA Class III cluster (LTB, LST1, NCR3, LTA, and NFKBIL1). Our findings suggest that FBXW7\u03b2 expression drives proinflammatory responses, which could contribute to normal B-cell development, leukemogenesis, and responses to anticancer therapies.<\/jats:p>","DOI":"10.1182\/bloodadvances.2022007910","type":"journal-article","created":{"date-parts":[[2022,11,2]],"date-time":"2022-11-02T19:17:17Z","timestamp":1667416637000},"page":"1077-1091","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":8,"title":["FBXW7\u03b2 isoform drives transcriptional activation of the proinflammatory TNF cluster in human pro-B cells"],"prefix":"10.1182","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9398-7363","authenticated-orcid":false,"given":"Scarlett Y.","family":"Yang","sequence":"first","affiliation":[{"name":"1Division of Cancer Pathobiology, Children\u2019s Hospital of Philadelphia, Philadelphia, PA"},{"name":"2Immunology Graduate Group, University of Pennsylvania, Philadelphia, PA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1463-3111","authenticated-orcid":false,"given":"Katharina E.","family":"Hayer","sequence":"additional","affiliation":[{"name":"1Division of Cancer Pathobiology, Children\u2019s Hospital of Philadelphia, Philadelphia, PA"},{"name":"3Department of Biomedical and Health Informatics, Children\u2019s Hospital of Philadelphia, Philadelphia, PA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hossein","family":"Fazelinia","sequence":"additional","affiliation":[{"name":"4The Proteomics Core, Children\u2019s Hospital of Philadelphia, Philadelphia, PA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9640-9158","authenticated-orcid":false,"given":"Lynn A.","family":"Spruce","sequence":"additional","affiliation":[{"name":"4The Proteomics Core, Children\u2019s Hospital of Philadelphia, Philadelphia, PA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6088-5010","authenticated-orcid":false,"given":"Mukta","family":"Asnani","sequence":"additional","affiliation":[{"name":"1Division of Cancer Pathobiology, Children\u2019s Hospital of Philadelphia, Philadelphia, PA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathryn L.","family":"Black","sequence":"additional","affiliation":[{"name":"1Division of Cancer Pathobiology, Children\u2019s Hospital of Philadelphia, Philadelphia, PA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0625-666X","authenticated-orcid":false,"given":"Ammar S.","family":"Naqvi","sequence":"additional","affiliation":[{"name":"1Division of Cancer Pathobiology, Children\u2019s Hospital of Philadelphia, Philadelphia, PA"},{"name":"3Department of Biomedical and Health Informatics, Children\u2019s Hospital of Philadelphia, Philadelphia, PA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7126-6226","authenticated-orcid":false,"given":"Vinodh","family":"Pillai","sequence":"additional","affiliation":[{"name":"5Division of Hematopathology, Children\u2019s Hospital of Philadelphia, Philadelphia, PA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3005-5048","authenticated-orcid":false,"given":"Yoseph","family":"Barash","sequence":"additional","affiliation":[{"name":"6Department of Genetics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1082-1545","authenticated-orcid":false,"given":"Kojo S. J.","family":"Elenitoba-Johnson","sequence":"additional","affiliation":[{"name":"7Department of Pathology & Laboratory Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2739-2206","authenticated-orcid":false,"given":"Andrei","family":"Thomas-Tikhonenko","sequence":"additional","affiliation":[{"name":"1Division of Cancer Pathobiology, Children\u2019s Hospital of Philadelphia, Philadelphia, PA"},{"name":"2Immunology Graduate Group, University of Pennsylvania, Philadelphia, PA"},{"name":"7Department of Pathology & Laboratory Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA"},{"name":"8Department of Pediatrics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"234","published-online":{"date-parts":[[2023,3,29]]},"reference":[{"issue":"3","key":"2023090715333815000_bib1","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1161\/CIRCRESAHA.115.307872","article-title":"RNA splicing: regulation and dysregulation in the heart","volume":"118","author":"van den Hoogenhof","year":"2016","journal-title":"Circ Res"},{"issue":"35","key":"2023090715333815000_bib2","doi-asserted-by":"crossref","first-page":"14324","DOI":"10.1073\/pnas.1311839110","article-title":"Differential splicing across immune system lineages","volume":"110","author":"Ergun","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"2023090715333815000_bib3","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1093\/intimm\/dxx026","article-title":"Splicing in immune cells-mechanistic insights and emerging topics","volume":"29","author":"Schaub","year":"2017","journal-title":"Int Immunol"},{"issue":"10","key":"2023090715333815000_bib4","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1084\/jem.20090756","article-title":"Distinct roles for E12 and E47 in B cell specification and the sequential rearrangement of immunoglobulin light chain loci","volume":"206","author":"Beck","year":"2009","journal-title":"J\u00a0Exp Med"},{"issue":"21","key":"2023090715333815000_bib5","first-page":"11357","article-title":"Aberrant splicing in B-cell acute lymphoblastic leukemia","volume":"46","author":"Black","year":"2018","journal-title":"Nucleic Acids Res"},{"issue":"18","key":"2023090715333815000_bib6","doi-asserted-by":"crossref","first-page":"e151627","DOI":"10.1172\/JCI151627","article-title":"RNA-binding proteins of COSMIC importance in cancer","volume":"131","author":"Choi","year":"2021","journal-title":"J\u00a0Clin Invest"},{"issue":"Database issue","key":"2023090715333815000_bib7","doi-asserted-by":"crossref","first-page":"D805","DOI":"10.1093\/nar\/gku1075","article-title":"COSMIC: exploring the world's knowledge of somatic mutations in human cancer","volume":"43","author":"Forbes","year":"2015","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"2023090715333815000_bib8","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/s12943-018-0857-2","article-title":"FBXW7: a critical tumor suppressor of human cancers","volume":"17","author":"Yeh","year":"2018","journal-title":"Mol Cancer"},{"issue":"12","key":"2023090715333815000_bib9","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1158\/0008-5472.CAN-19-2247","article-title":"FBXW7 triggers degradation of KMT2D to favor growth of diffuse large B-cell lymphoma cells","volume":"80","author":"Saffie","year":"2020","journal-title":"Cancer Res"},{"issue":"3","key":"2023090715333815000_bib10","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.ccr.2013.01.025","article-title":"Regulation of c-Myc ubiquitination controls chronic myelogenous leukemia initiation and progression","volume":"23","author":"Reavie","year":"2013","journal-title":"Cancer Cell"},{"issue":"4","key":"2023090715333815000_bib11","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/ncb2463","article-title":"Fbxw7alpha- and GSK3-mediated degradation of p100 is a pro-survival mechanism in multiple myeloma","volume":"14","author":"Busino","year":"2012","journal-title":"Nat Cell Biol"},{"issue":"2","key":"2023090715333815000_bib12","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/nrc2290","article-title":"FBW7 ubiquitin ligase: a tumour suppressor at the crossroads of cell division, growth and differentiation","volume":"8","author":"Welcker","year":"2008","journal-title":"Nat Rev Cancer"},{"issue":"4","key":"2023090715333815000_bib13","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.ccell.2014.09.013","article-title":"Tumor suppression by the Fbw7 ubiquitin ligase: mechanisms and opportunities","volume":"26","author":"Davis","year":"2014","journal-title":"Cancer Cell"},{"issue":"18","key":"2023090715333815000_bib14","doi-asserted-by":"crossref","first-page":"3627","DOI":"10.1128\/MCB.00535-13","article-title":"Parkin-dependent degradation of the F-box protein Fbw7beta promotes neuronal survival in response to oxidative stress by stabilizing Mcl-1","volume":"33","author":"Ekholm-Reed","year":"2013","journal-title":"Mol Cell Biol"},{"issue":"4","key":"2023090715333815000_bib15","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.bbrc.2007.01.080","article-title":"The FBXW7 beta-form is suppressed in human glioma cells","volume":"354","author":"Gu","year":"2007","journal-title":"Biochem Biophys Res Commun"},{"key":"2023090715333815000_bib16","doi-asserted-by":"crossref","first-page":"101315","DOI":"10.1016\/j.tice.2019.101315","article-title":"The expression characteristics of FBXW7 in human testis suggest its function is different from that in mice","volume":"62","author":"Zhou","year":"2020","journal-title":"Tissue Cell"},{"issue":"8","key":"2023090715333815000_bib17","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/s41419-020-02873-4","article-title":"Isoform specific FBXW7 mediates NOTCH1 Abruptex mutation C1133Y deregulation in oral squamous cell carcinoma","volume":"11","author":"Zheng","year":"2020","journal-title":"Cell Death Dis"},{"issue":"23","key":"2023090715333815000_bib18","doi-asserted-by":"crossref","first-page":"4620","DOI":"10.1038\/s41388-019-0746-1","article-title":"Downregulation of specific FBXW7 isoforms with differential effects in T-cell lymphoblastic lymphoma","volume":"38","author":"Vazquez-Dominguez","year":"2019","journal-title":"Oncogene"},{"issue":"6","key":"2023090715333815000_bib19","doi-asserted-by":"crossref","first-page":"R105","DOI":"10.1186\/bcr2788","article-title":"Inactivation of FBXW7\/hCDC4-beta expression by promoter hypermethylation is associated with favorable prognosis in primary breast cancer","volume":"12","author":"Akhoondi","year":"2010","journal-title":"Breast Cancer Res"},{"issue":"4","key":"2023090715333815000_bib20","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1111\/j.1349-7006.2011.01851.x","article-title":"Fbxw7beta resides in the endoplasmic reticulum membrane and protects cells from oxidative stress","volume":"102","author":"Matsumoto","year":"2011","journal-title":"Cancer Sci"},{"issue":"2","key":"2023090715333815000_bib21","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1158\/2643-3230.BCD-21-0087","article-title":"Modulation of CD22 protein expression in childhood leukemia by pervasive splicing aberrations: implications for CD22-directed immunotherapies","volume":"3","author":"Zheng","year":"2022","journal-title":"Blood Cancer Discov"},{"issue":"1","key":"2023090715333815000_bib22","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1186\/s13059-021-02411-1","article-title":"Direct long-read RNA sequencing identifies a subset of questionable exitrons likely arising from reverse transcription artifacts","volume":"22","author":"Schulz","year":"2021","journal-title":"Genome Biol"},{"issue":"4","key":"2023090715333815000_bib23","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1038\/s41375-019-0580-z","article-title":"Retention of CD19 intron 2 contributes to CART-19 resistance in leukemias with subclonal frameshift mutations in CD19","volume":"34","author":"Asnani","year":"2020","journal-title":"Leukemia"},{"key":"2023090715333815000_bib24","doi-asserted-by":"crossref","first-page":"e11752","DOI":"10.7554\/eLife.11752","article-title":"A\u00a0new view of transcriptome complexity and regulation through the lens of local splicing variations","volume":"5","author":"Vaquero-Garcia","year":"2016","journal-title":"ELife"},{"issue":"1","key":"2023090715333815000_bib25","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s13059-014-0560-6","article-title":"Gateways to the FANTOM5 promoter level mammalian expression atlas","volume":"16","author":"Lizio","year":"2015","journal-title":"Genome Biol"},{"issue":"7","key":"2023090715333815000_bib26","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.1182\/blood-2015-11-680843","article-title":"Long noncoding RNAs in B-cell development and activation","volume":"128","author":"Brazao","year":"2016","journal-title":"Blood"},{"issue":"6","key":"2023090715333815000_bib27","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1083\/jcb.200802076","article-title":"Isoform- and cell cycle-dependent substrate degradation by the Fbw7 ubiquitin ligase","volume":"181","author":"Grim","year":"2008","journal-title":"J\u00a0Cell Biol"},{"issue":"6","key":"2023090715333815000_bib28","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/ncb3358","article-title":"The increasing complexity of the ubiquitin code","volume":"18","author":"Yau","year":"2016","journal-title":"Nat Cell Biol"},{"issue":"Database issue","key":"2023090715333815000_bib29","doi-asserted-by":"crossref","first-page":"D561","DOI":"10.1093\/nar\/gkq973","article-title":"The STRING database in 2011: functional interaction networks of proteins, globally integrated and scored","volume":"39","author":"Szklarczyk","year":"2011","journal-title":"Nucleic Acids Res"},{"issue":"Pt 2","key":"2023090715333815000_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.semcancer.2020.02.017","article-title":"Recent insight into the role of FBXW7 as a tumor suppressor","volume":"67","author":"Yumimoto","year":"2020","journal-title":"Semin Cancer Biol"},{"issue":"7","key":"2023090715333815000_bib31","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1016\/j.cell.2013.05.041","article-title":"The ubiquitin ligase FBXW7 modulates leukemia-initiating cell activity by regulating MYC stability","volume":"153","author":"King","year":"2013","journal-title":"Cell"},{"issue":"6","key":"2023090715333815000_bib32","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.4049\/jimmunol.1901156","article-title":"E3 ubiquitin ligase Fbw7 regulates the survival of mature B cells","volume":"204","author":"Ramezani-Rad","year":"2020","journal-title":"J\u00a0Immunol"},{"issue":"20","key":"2023090715333815000_bib33","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1016\/j.cub.2004.09.083","article-title":"A\u00a0nucleolar isoform of the Fbw7 ubiquitin ligase regulates c-Myc and cell size","volume":"14","author":"Welcker","year":"2004","journal-title":"Curr Biol"},{"issue":"5","key":"2023090715333815000_bib34","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/j.1349-7006.2003.tb01460.x","article-title":"hCDC4b, a regulator of cyclin E, as a direct transcriptional target of p53","volume":"94","author":"Kimura","year":"2003","journal-title":"Cancer Sci"},{"issue":"7018","key":"2023090715333815000_bib35","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/nature03155","article-title":"Fbxw7\/Cdc4 is a p53-dependent, haploinsufficient tumour suppressor gene","volume":"432","author":"Mao","year":"2004","journal-title":"Nature"},{"issue":"22","key":"2023090715333815000_bib36","doi-asserted-by":"crossref","first-page":"3547","DOI":"10.4161\/cc.26591","article-title":"Differential regulation of FBXW7 isoforms by various stress stimuli","volume":"12","author":"Sionov","year":"2013","journal-title":"Cell Cycle"},{"issue":"4","key":"2023090715333815000_bib37","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/s41580-019-0110-x","article-title":"The multiple mechanisms that regulate p53 activity and cell fate","volume":"20","author":"Hafner","year":"2019","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1","key":"2023090715333815000_bib38","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1186\/1471-2164-7-281","article-title":"Evolution and comparative analysis of the MHC Class III inflammatory region","volume":"7","author":"Deakin","year":"2006","journal-title":"BMC Genomics"},{"issue":"5","key":"2023090715333815000_bib39","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1111\/bjh.13760","article-title":"Lymphotoxin-beta receptor in microenvironmental cells promotes the development of T-cell acute lymphoblastic leukaemia with cortical\/mature immunophenotype","volume":"171","author":"Fernandes","year":"2015","journal-title":"Br J Haematol"},{"issue":"1","key":"2023090715333815000_bib40","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1038\/ncomms1975","article-title":"Proteomic screen reveals Fbw7 as a modulator of the NF-kappaB pathway","volume":"3","author":"Arabi","year":"2012","journal-title":"Nat Commun"},{"issue":"5","key":"2023090715333815000_bib41","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.celrep.2012.04.002","article-title":"SCF(Fbw7) modulates the NFkB signaling pathway by targeting NFkB2 for ubiquitination and destruction","volume":"1","author":"Fukushima","year":"2012","journal-title":"Cell Rep"},{"issue":"8","key":"2023090715333815000_bib42","first-page":"1707","article-title":"Involvement of B lymphocytes in the growth inhibition of human pulmonary melanoma metastases in athymic nu\/nu mice by an antibody-lymphotoxin fusion protein","volume":"56","author":"Reisfeld","year":"1996","journal-title":"Cancer Res"},{"issue":"19","key":"2023090715333815000_bib43","doi-asserted-by":"crossref","first-page":"9617","DOI":"10.1158\/0008-5472.CAN-06-0217","article-title":"Targeting the lymphotoxin-beta receptor with agonist antibodies as a potential cancer therapy","volume":"66","author":"Lukashev","year":"2006","journal-title":"Cancer Res"},{"issue":"2","key":"2023090715333815000_bib44","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S1074-7613(01)00094-2","article-title":"Targeting of lymphotoxin-alpha to the tumor elicits an efficient immune response associated with induction of peripheral lymphoid-like tissue","volume":"14","author":"Schrama","year":"2001","journal-title":"Immunity"},{"issue":"7902","key":"2023090715333815000_bib45","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1038\/s41586-022-04494-7","article-title":"A\u00a0genome-scale screen for synthetic drivers of T cell proliferation","volume":"603","author":"Legut","year":"2022","journal-title":"Nature"},{"issue":"5","key":"2023090715333815000_bib46","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1182\/blood-2003-11-4039","article-title":"Apoptotic resistance to ionizing radiation in pediatric B-precursor acute lymphoblastic leukemia frequently involves increased NF-kappaB survival pathway signaling","volume":"104","author":"Weston","year":"2004","journal-title":"Blood"},{"issue":"15","key":"2023090715333815000_bib47","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1182\/blood-2014-01-547943","article-title":"IKK-dependent activation of NF-kappaB contributes to myeloid and lymphoid leukemogenesis by BCR-ABL1","volume":"123","author":"Hsieh","year":"2014","journal-title":"Blood"},{"key":"2023090715333815000_bib48","doi-asserted-by":"crossref","first-page":"120","DOI":"10.3389\/fonc.2013.00120","article-title":"Targeting nuclear factor-kappa B to overcome resistance to chemotherapy","volume":"3","author":"Godwin","year":"2013","journal-title":"Front Oncol"},{"issue":"1","key":"2023090715333815000_bib49","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/1476-4598-12-86","article-title":"The complexity of NF-kappaB signaling in inflammation and cancer","volume":"12","author":"Hoesel","year":"2013","journal-title":"Mol Cancer"},{"issue":"10","key":"2023090715333815000_bib50","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1038\/s41375-019-0454-4","article-title":"Transient stabilization, rather than inhibition, of MYC amplifies extrinsic apoptosis and therapeutic responses in refractory B-cell lymphoma","volume":"33","author":"Harrington","year":"2019","journal-title":"Leukemia"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/7\/7\/1077\/2076608\/blooda_adv-2022-007910-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/7\/7\/1077\/2076608\/blooda_adv-2022-007910-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,7]],"date-time":"2023-09-07T15:34:14Z","timestamp":1694100854000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/7\/7\/1077\/486951\/FBXW7-isoform-drives-transcriptional-activation-of"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,29]]},"references-count":50,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,4,11]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2022007910","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,29]]}}}